Year |
Citation |
Score |
2023 |
Jorgensen AM, Gorkun A, Mahajan N, Willson K, Clouse C, Jeong CG, Varkey M, Wu M, Walker SJ, Molnar JA, Murphy SV, Lee SJ, Yoo JJ, Soker S, Atala A. Multicellular bioprinted skin facilitates human-like skin architecture in vivo. Science Translational Medicine. 15: eadf7547. PMID 37792956 DOI: 10.1126/scitranslmed.adf7547 |
0.506 |
|
2019 |
Jorgensen AM, Varkey M, Gorkun A, Clouse C, Xu L, Chou Z, Murphy S, Molnar J, Lee SJ, Yoo JJ, Soker S, Atala A. Bioprinted Skin Recapitulates Normal Collagen Remodeling in Full-thickness Wounds. Tissue Engineering. Part A. PMID 31861970 DOI: 10.1089/Ten.Tea.2019.0319 |
0.547 |
|
2019 |
Varkey M, Visscher DO, van Zuijlen PPM, Atala A, Yoo JJ. Skin bioprinting: the future of burn wound reconstruction? Burns & Trauma. 7: 4. PMID 30805375 DOI: 10.1186/S41038-019-0142-7 |
0.48 |
|
2015 |
Varkey M, Ding J, Tredget EE. Advances in Skin Substitutes-Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing. Journal of Functional Biomaterials. 6: 547-63. PMID 26184327 DOI: 10.3390/Jfb6030547 |
0.667 |
|
2015 |
Medina A, Ma Z, Varkey M, Liu H, Iwashina T, Ding J, Tredget EE. Fibrocytes participate in the development of heterotopic ossification. Journal of Burn Care & Research : Official Publication of the American Burn Association. 36: 394-404. PMID 25051520 DOI: 10.1097/Bcr.0000000000000102 |
0.515 |
|
2014 |
Varkey M, Ding J, Tredget EE. The effect of keratinocytes on the biomechanical characteristics and pore microstructure of tissue engineered skin using deep dermal fibroblasts. Biomaterials. 35: 9591-8. PMID 25176070 DOI: 10.1016/J.Biomaterials.2014.07.048 |
0.661 |
|
2014 |
Varkey M, Ding J, Tredget EE. Fibrotic remodeling of tissue-engineered skin with deep dermal fibroblasts is reduced by keratinocytes. Tissue Engineering. Part A. 20: 716-27. PMID 24090416 DOI: 10.1089/ten.TEA.2013.0434 |
0.67 |
|
2014 |
Varkey M, Ding J, Tredget EE. Superficial dermal fibroblasts enhance basement membrane and epidermal barrier formation in tissue-engineered skin: implications for treatment of skin basement membrane disorders. Tissue Engineering. Part A. 20: 540-52. PMID 24004160 DOI: 10.1089/Ten.Tea.2013.0160 |
0.661 |
|
2012 |
Honardoust D, Ding J, Varkey M, Shankowsky HA, Tredget EE. Deep dermal fibroblasts refractory to migration and decorin-induced apoptosis contribute to hypertrophic scarring. Journal of Burn Care & Research : Official Publication of the American Burn Association. 33: 668-77. PMID 22210076 DOI: 10.1097/Bcr.0B013E31824088E3 |
0.636 |
|
2012 |
Honardoust D, Varkey M, Marcoux Y, Shankowsky HA, Tredget EE. Reduced decorin, fibromodulin, and transforming growth factor-β3 in deep dermis leads to hypertrophic scarring. Journal of Burn Care & Research : Official Publication of the American Burn Association. 33: 218-27. PMID 22079916 DOI: 10.1097/Bcr.0B013E3182335980 |
0.607 |
|
2011 |
Mostafa NZ, Uludağ H, Varkey M, Dederich DN, Doschak MR, El-Bialy TH. In vitro osteogenic induction of human gingival fibroblasts for bone regeneration. The Open Dentistry Journal. 5: 139-45. PMID 21915227 DOI: 10.2174/1874210601105010139 |
0.397 |
|
2011 |
Varkey M, Ding J, Tredget EE. Differential collagen-glycosaminoglycan matrix remodeling by superficial and deep dermal fibroblasts: potential therapeutic targets for hypertrophic scar. Biomaterials. 32: 7581-91. PMID 21802722 DOI: 10.1016/J.Biomaterials.2011.06.070 |
0.67 |
|
2011 |
Honardoust D, Varkey M, Hori K, Ding J, Shankowsky HA, Tredget EE. Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 19: 368-78. PMID 21518082 DOI: 10.1111/J.1524-475X.2011.00677.X |
0.681 |
|
2007 |
Varkey M, Kucharski C, Doschak MR, Winn SR, Brochmann EJ, Murray S, Matyas JR, Zernicke RF, Uludag H. Osteogenic response of bone marrow stromal cells from normal and ovariectomized rats treated with a low dose of basic fibroblast growth factor. Tissue Engineering. 13: 809-17. PMID 17394387 DOI: 10.1089/Ten.2006.0348 |
0.342 |
|
2006 |
Varkey M, Kucharski C, Haque T, Sebald W, UludaÄŸ H. In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments. Clinical Orthopaedics and Related Research. 443: 113-23. PMID 16462434 DOI: 10.1097/01.Blo.0000200236.84189.87 |
0.317 |
|
2004 |
Varkey M, Gittens SA, Uludag H. Growth factor delivery for bone tissue repair: an update. Expert Opinion On Drug Delivery. 1: 19-36. PMID 16296718 DOI: 10.1517/17425247.1.1.19 |
0.367 |
|
Show low-probability matches. |